Stocks · Korea
200230
KOSDAQ
Telcon RF Pharmaceutical
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+4.07%
1M+3.37%
3M+9.79%
6M-68.14%
1Y-78.49%
YTD-71.45%
52W high11,026원
52W low1,612원
From 52W high-79.14%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 278억 | -41억 | -421억 | -14.6% |
| 2023 | 363억 | 10억 | 139억 | 2.7% |
| 2024 | 379억 | -70,548,303원 | -265억 | -0.2% |
| 2025 | 432억 | 7억 | -114억 | 1.7% |
| Quarterly | ||||
| 2024 4Q | 138억 | 31억 | -122억 | 22.6% |
| 2025 1Q | 100억 | -15억 | -146억 | -15.1% |
| 2025 2Q | 100억 | -4억 | -18억 | -4.0% |
| 2025 3Q | 98억 | -8,655,775원 | -48억 | -0.1% |
| 2025 4Q | 133억 | 26억 | 98억 | 19.7% |
| 2026 1Q | 97억 | -14억 | -115억 | -14.7% |
Company
Address: 경기도 용인시 기흥구 공세로 54 -
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 대성미생물 | 229억 | 38.41 | 0.65 | -3.37% |
| 서울제약 | 225억 | 29.75 | 0.55 | -1.07% |
| 에이프로젠바이오로직스 | 250억 | — | 0.10 | -10.83% |
| 풍전약품 | 225억 | 77.83 | 0.57 | -7.34% |
| 샤페론 | 252억 | — | 1.02 | +6.67% |
| 엠에프씨 | 224억 | 25.34 | 0.70 | +4.61% |
Recent filings
- 2026-09-29주요사항보고서(자기전환사채만기전취득결정) Major
- 2026-08-14반기보고서 (2026.06)
- 2026-07-06주요사항보고서(유상증자결정) Major
- 2026-05-27주요사항보고서(자기전환사채만기전취득결정) Major
- 2026-05-15분기보고서 (2026.03)
- 2026-04-17[기재정정]주요사항보고서(감자결정) Major
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.